Clinical Trials Browser

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT00038727 2021-12-28

DPPOS

Phase 3 Unknown

2,779 enrolled 16 charts

Other

Diabetes Mellitus, Diabetes Mellitus, Type 2, Neoplasms, Obesity, Prediabetic State

NCT04780854 2021-07-28

Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)

Phase 2 Unknown

68 enrolled

Tumor-Agnostic

Neoplasms

NCT03086733 2020-08-19

Metcore

Phase 2 Completed

28 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT04001725 2019-11-13

OPTIMAL

Phase 2 Unknown

110 enrolled

BreastCNSDermatologicThoracic

Brain Neoplasms, Breast Neoplasms, Diabetes Mellitus, Lung Neoplasms, Melanoma, Neoplasms

NCT03874000 2019-03-19

SMART

Phase 2 Unknown

43 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01442870 2017-05-09

Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy

Phase 1 Completed

105 enrolled

Tumor-Agnostic

Neoplasms

Clinical Trials

PragMet

Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

MAST

Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers

Metformin in Children With Relapsed or Refractory Solid Tumors

METRICS

DPPOS

Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)

Metcore

OPTIMAL

SMART

Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy